news semaglutide GLP‑1 Drugs May Be the Next Tool in the Fight Against Addiction | Health A pilot program will cover
Description
Together, these three mechanisms work in concert to produce the unprecedented 24.2% average weight loss observed in 48-week clinical trials
GLP-1 Stomach Paralysis Lawsuits Claims that GLP-1 drug makers allegedly failed to warn about the risk of gastroparesis, or stomach paralysis, sparked the first wave of litigation against the manufacturers of the popular diabetes and weight loss medications
These findings highlight a potential ocular safety signal for GLP-1 RAs that warrants further investigation
2019;366:l4898
